跳至主要内容
临床试验/JPRN-UMIN000028765
JPRN-UMIN000028765招募中未知

Effect of Symbicort nasal exhalation for eosinophilic rhinosinusitis with bronchial asthma - Nasal exhalation of Symbicort for ECRS with asthma

Department of Allergy and pulmonary medicine, Mitsubishi Kyoto Hospital0 个研究点目标入组 40 人开始时间: 2017年8月23日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) intranasal steroid, systemic corticosteroid, depo-triamcinolone, Shinni-Seihai Tou, mepolizumab are prescribed. 2)Systemic steroid prescribed twice or more within one month. 3)Omalizumab or LTRA is begun within 6 month. 4)Who has a complication considered to affect the evaluation of this study.

研究者

发起方
Department of Allergy and pulmonary medicine, Mitsubishi Kyoto Hospital

相似试验